Bottom line
How much do BHCHX and LHCOX overlap?
52% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 46.1% of BHCHX's assets and 43.8% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings BHCHX and LHCOX have in common
| Holding | % of BHCHX | % of LHCOX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.66% | 10.40% | 10.40% |
| Johnson & Johnson | 5.56% | 4.96% | 4.96% |
| Thermo Fisher Scientific Inc | 3.91% | 2.31% | 2.31% |
| UnitedHealth Group Inc | 3.28% | 5.39% | 3.28% |
| Edwards Lifesciences Corp | 2.64% | 1.78% | 1.78% |
| Vertex Pharmaceuticals Inc | 2.61% | 2.24% | 2.24% |
| AstraZeneca PLC | 2.49% | 1.97% | 1.97% |
| Guardant Health Inc | 2.17% | 2.61% | 2.17% |
| Madrigal Pharmaceuticals Inc | 2.12% | 1.91% | 1.91% |
| Revolution Medicines Inc | 2.05% | 1.67% | 1.67% |
| Gilead Sciences Inc | 1.99% | 3.53% | 1.99% |
| Natera Inc | 1.93% | 3.60% | 1.93% |
| Protagonist Therapeutics Inc | 1.72% | 1.44% | 1.44% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BHCHX
- Mettler-Toledo International Inc — 5.60%
- Argenx SE — 4.23%
- Roivant Sciences Ltd — 3.88%
- Teva Pharmaceutical Industries Ltd — 3.86%
- Welltower Inc — 3.38%
- RadNet Inc — 3.24%
- Billiontoone Inc — 2.84%
- Merck & Co Inc — 2.48%
- Elanco Animal Health Inc — 2.05%
- Kymera Therapeutics Inc — 2.01%
- Intuitive Surgical Inc — 1.74%
- Elevance Health Inc — 1.69%
Only in LHCOX
- Novartis AG — 4.19%
- CVS Health Corp — 3.33%
- Galderma Group AG — 2.60%
- Cogent Biosciences Inc — 2.27%
- 10X Genomics Inc — 2.16%
- BeOne Medicines Ltd — 2.06%
- Ascendis Pharma A/S — 1.99%
- Bridgebio Pharma Inc — 1.84%
- Arrowhead Pharmaceuticals Inc — 1.52%
- Dianthus Therapeutics Inc — 1.44%
- Adaptive Biotechnologies Corp — 1.42%
- Illumina Inc — 1.42%
Asset mix
| Asset type | BHCHX | LHCOX |
|---|---|---|
| Stocks | 97.7% | 98.2% |
| Repurchase agreements | — | 1.2% |
| Cash & short-term funds | — | 0.8% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | BHCHX | LHCOX |
|---|---|---|
| US | 79.7% | 78.5% |
| CH | — | 8.8% |
| NL | 4.5% | 2.2% |
| BM | 3.9% | 1.1% |
| IL | 3.9% | 1.2% |
| GB | 2.5% | 2.0% |
| DK | 0.4% | 2.0% |
| CA | 1.9% | 0.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do BHCHX and LHCOX overlap?
What stocks do BHCHX and LHCOX have in common?
Should I own both BHCHX and LHCOX?
Which holds more stocks, BHCHX or LHCOX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.